Orthofix Medical Inc. OFIX
7.18 USD +0.06 (+0.84%)
At closeNov 11, 2026, 5:56 PM EST
7.16 -0.02 -0.28%
After hours · Nov 11, 5:56 PM ET
6.94 Day range 7.39
7.12 52-week range 16.20
- YTD
- -52.64%
- 1 year
- -53.32%
News
benzinga.com 12 Health Care Stocks Moving In Wednesday's After-Market Session Gainers Can Fite Biopharma (AMEX:CANF) stock rose 7.1% to $1.66 during Wednesday's after-market session. The market value of their outstanding shares is at $3.5 million. iTonic Holdings (NASDAQ:ITOC)…
marketbeat.com Orthofix Medical Q3 Earnings Call Highlights Orthofix Medical NASDAQ: OFIX lowered its 2026 outlook after third-quarter results fell short of management's expectations, as softer U.S. spine procedure volumes and supplier delays constrained its…
seekingalpha.com Orthofix Medical Inc. (OFIX) Q3 2026 Earnings Call Transcript Orthofix Medical Inc. (OFIX) Q3 2026 Earnings Call Transcript
zacks.com Orthofix (OFIX) Surpasses Q3 Earnings Estimates Orthofix (OFIX) came out with quarterly earnings of $0.18 per share, beating the Zacks Consensus Estimate of $0.11 per share. This compares to earnings of $0.2 per share a year ago.
benzinga.com Orthofix Medical Q3 2026 Earnings Call Transcript Orthofix Medical (NASDAQ:OFIX) reported third-quarter financial results on Monday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is brought to…
benzinga.com Orthofix Medical Lowers FY2026 Sales Guidance from $845.000M-$855.000M to $825.000M-$830.000M vs $851.203M Est Orthofix Medical (NASDAQ:OFIX) lowers FY2026 sales outlook from $845.000 million-$855.000 million to $825.000 million-$830.000 million vs $851.203 million estimate.
businesswire.com Orthofix Reports Third Quarter 2026 Results and Revises Full-Year 2026 Guidance LEWISVILLE, Texas--(BUSINESS WIRE)--Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today reported financial results for the third quarter ended September 30, 2026,…
zacks.com Orthofix (OFIX) Surges 11.0%: Is This an Indication of Further Gains? Orthofix (OFIX) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
businesswire.com Orthofix to Report Third Quarter 2026 Financial Results LEWISVILLE, Texas--(BUSINESS WIRE)--Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today announced that it will release its third quarter 2026 financial results on…
prnewswire.com SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of an Investigation Concerning Possible Breaches of Fiduciary Duties by Certain Officers and Directors of Orthofix Medical Inc. (NASDAQ: OFIX) NEW YORK, Oct. 21, 2026 /PRNewswire/ -- Levi & Korsinsky announces that it has commenced an investigation of Orthofix Medical Inc. (NASDAQ: OFIX) concerning possible breaches of fiduciary duties. If…
prnewswire.com Did Orthofix Medical Inc. Insiders Breach their Fiduciary Duties to Shareholders? Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be…
prnewswire.com SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of an Investigation Concerning Possible Breaches of Fiduciary Duties by Certain Officers and Directors of Orthofix Medical Inc. (NASDAQ: OFIX) NEW YORK, Oct. 8, 2026 /PRNewswire/ -- Levi & Korsinsky announces that it has commenced an investigation of Orthofix Medical Inc. (NASDAQ: OFIX) concerning possible breaches of fiduciary duties. If…
marketbeat.com Orthofix Medical Sees Reimbursement Rebound, but Spine Slump Clouds Outlook Orthofix Medical NASDAQ: OFIX executives said the company's updated outlook reflects the restoration of bone growth stimulation reimbursement, improving trends in biologics and limb reconstruction,…
benzinga.com Canaccord Genuity Maintains Buy on Orthofix Medical, Lowers Price Target to $13 Canaccord Genuity analyst Caitlin Burrows maintains Orthofix Medical (NASDAQ:OFIX) with a Buy and lowers the price target from $18 to $13.- benzinga.com 12 Health Care Stocks Moving In Wednesday's After-Market Session Gainers Creative Medical Tech (NASDAQ:CELZ) stock moved upwards by 31.4% to $0.88 during Wednesday's after-market session. The company's market cap stands at $4.2 million. Caris Life Sciences…
marketbeat.com Orthofix Medical Q2 Earnings Call Highlights Orthofix Medical NASDAQ: OFIX reported second-quarter results that management said reflected improving operating trends across several businesses, while continued weakness among smaller U.S. spine…
seekingalpha.com Orthofix Medical Inc. (OFIX) Q2 2026 Earnings Call Transcript Orthofix Medical Inc. (OFIX) Q2 2026 Earnings Call Transcript
zacks.com Bet on 5 Top-Ranked Stocks With Rising P/E Tap five stocks with increasing P/E ratios to try out an out-of-the-box approach.
zacks.com Orthofix (OFIX) Q2 Earnings and Revenues Surpass Estimates Orthofix (OFIX) came out with quarterly earnings of $0.07 per share, beating the Zacks Consensus Estimate of a loss of $0.03 per share. This compares to earnings of $0.13 per share a year ago.
benzinga.com 12 Health Care Stocks Moving In Wednesday's Pre-Market Session Gainers Bluejay Diagnostics (NASDAQ:BJDX) shares moved upwards by 43.0% to $1.43 during Wednesday's pre-market session. The company's market cap stands at $1.0 million. Estrella Immunopharma…- benzinga.com Orthofix Medical Raises FY2026 Sales Guidance from $838.000M-$848.000M to $845.000M-$855.000M vs $843.311M Est Orthofix Medical (NASDAQ:OFIX) raises FY2026 sales outlook from $838.000 million-$848.000 million to $845.000 million-$855.000 million vs $843.311 million estimate.
benzinga.com Orthofix Medical Q2 Adj. EPS $0.07 Beats $(0.41) Estimate, Sales $210.933M Beat $209.277M Estimate Orthofix Medical (NASDAQ:OFIX) reported quarterly earnings of $0.07 per share which beat the analyst consensus estimate of $(0.41) by 117.07 percent. This is a 46.15 percent decrease over earnings of…
businesswire.com Orthofix Reports Second Quarter 2026 Results Reflecting Continued Operational Progress LEWISVILLE, Texas--(BUSINESS WIRE)--Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today reported its financial results for the second quarter ended June 30, 2026,…
gurufocus.com Did Orthofix Medical Inc. Insiders Breach their Fiduciary Duties to Shareholders? Did Orthofix Medical Inc. Insiders Breach their Fiduciary Duties to Shareholders? PR Newswire NEW YORK, July 29, 2
zacks.com Analysts Estimate Orthofix (OFIX) to Report a Decline in Earnings: What to Look Out for Orthofix (OFIX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
prnewswire.com Did Orthofix Medical Inc. Insiders Breach their Fiduciary Duties to Shareholders? Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be…
zacks.com Wall Street Analysts Think Orthofix (OFIX) Could Surge 33.28%: Read This Before Placing a Bet The average of price targets set by Wall Street analysts indicates a potential upside of 33.3% in Orthofix (OFIX). While the effectiveness of this highly sought-after metric is questionable, the…
benzinga.com These 7 Small Caps Are on Fire as the Second Half Begins: Here’s Why Seven small-cap stocks have surged as much as 123% in early July on buyouts, FDA developments, refinancing deals and short squeezes.
prnewswire.com MedTech Pioneer Max Reinhardt Joins eXeX to Drive Canopus Platform Growth The Johnson & Johnson, Pacira BioSciences and Orthofix executive takes charge of commercial execution as adoption of Canopus by eXeX accelerates across hospital systems in the United States and…
benzinga.com Reported July 2, 2026: Orthofix Medical Says Medicare Will Restore Pre-May 18 Reimbursement Rates For Bone Growth Stimulators After CMS Reversal On April 16, 2026, the U.S. Food and Drug Administration ("FDA") issued a final order reclassifying non-invasive bone growth stimulators from Class III to Class II devices. Following that order, the…
benzinga.com Terawulf, Ceva, Western Digital And Other Big Stocks Moving Higher On Monday Stocks mixed, Dow falls 100 points. Terawulf Inc (NASDAQ: WULF) rises after lease deal. Other big gainers: OFIX, AXTI, SHAZ, IREN, CEVA, IMOS, CRDO, HUT, BFLY, CHRN, BE, ALAB, SIMO.
benzinga.com 12 Health Care Stocks Moving In Thursday's After-Market Session Gainers Seer (NASDAQ:SEER) stock moved upwards by 33.3% to $2.16 during Thursday's after-market session. The market value of their outstanding shares is at $89.6 million. Universe Pharmaceuticals…
benzinga.com Alpha Buying: Wall Street Gave Up. Management Didn't. 
benzinga.com Canaccord Genuity Maintains Buy on Orthofix Medical, Lowers Price Target to $18 Canaccord Genuity analyst Caitlin Burrows maintains Orthofix Medical (NASDAQ:OFIX) with a Buy and lowers the price target from $20 to $18.
benzinga.com Chevron To Rally Around 12%? Here Are 10 Top Analyst Forecasts For Friday Get the latest analyst rating changes for top companies on Wall Street, including upgrades and downgrades. View complete details at Benzinga.
benzinga.com Barrington Research Maintains Outperform on Orthofix Medical, Lowers Price Target to $15 Barrington Research analyst Michael Petusky maintains Orthofix Medical (NASDAQ:OFIX) with a Outperform and lowers the price target from $17 to $15.
benzinga.com Stifel Maintains Buy on Orthofix Medical, Lowers Price Target to $15 Stifel analyst Thomas Stephan maintains Orthofix Medical (NASDAQ:OFIX) with a Buy and lowers the price target from $18 to $15.- benzinga.com Orthofix Medical Announces New Pediatric Limb Reconstruction Innovations That Expand Treatment Options For Pediatric And Small Stature Patients The Company will highlight these advances at the Pediatric Orthopedic Society of North America (POSNA) 2026 Annual Meeting, which takes place May 6-8, 2026, at the Rosen Shingle Creek Hotel in…
- benzinga.com Full Transcript: Orthofix Medical Q1 2026 Earnings Call
- benzinga.com Orthofix Medical Affirms FY2026 Sales Guidance of $850.000M-$860.000M vs $855.606M Est Orthofix Medical (NASDAQ:OFIX) affirms FY2026 sales outlook from $850.000 million-$860.000 million to $850.000 million-$860.000 million vs $855.606 million estimate.
- benzinga.com Orthofix Medical Q1 Adj. EPS $(0.13) Beats $(0.68) Estimate, Sales $196.700M Beat $193.985M Estimate Orthofix Medical (NASDAQ:OFIX) reported quarterly losses of $(0.13) per share which beat the analyst consensus estimate of $(0.68) by 80.88 percent. This is a 62.5 percent decrease over losses of…
benzinga.com Earnings Scheduled For May 5, 2026 
benzinga.com Orthofix Reaffirms FY26 Net Sales Outlook Of $850M-$860M; Reports Preliminary Q1 Net Sales Of ~$196.7M, And Non-GAAP Pro Forma Net Sales Of ~$196.4M Company Reports Preliminary First Quarter 2026 Net Sales and Reaffirms 2026 OutlookOrthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today announced a strategic…
benzinga.com A Glimpse Into The Expert Outlook On Orthofix Medical Through 5 Analysts - benzinga.com Stifel Maintains Buy on Orthofix Medical, Lowers Price Target to $18 Stifel analyst Thomas Stephan maintains Orthofix Medical (NASDAQ:OFIX) with a Buy and lowers the price target from $22 to $18.
- benzinga.com Canaccord Genuity Maintains Buy on Orthofix Medical, Lowers Price Target to $20 Canaccord Genuity analyst Caitlin Burrows maintains Orthofix Medical (NASDAQ:OFIX) with a Buy and lowers the price target from $24 to $20.
benzinga.com Orthofix Medical Earnings Review: Q4 Summary - benzinga.com Orthofix Medical Sees FY2026 Sales $850.000M-$860.000M vs $862.758M Est Orthofix Medical (NASDAQ:OFIX) sees FY2026 sales of $850.000 million-$860.000 million vs $862.758 million analyst estimate.
- benzinga.com Orthofix Medical Q4 Adj. EPS $0.24 Beats $0.12 Estimate, Sales $219.911M Beat $218.861M Estimate. Orthofix Medical (NASDAQ:OFIX) reported quarterly earnings of $0.24 per share which beat the analyst consensus estimate of $0.12 by 100 percent. This is a 1100 percent increase over earnings of $0.02…
- benzinga.com Earnings Scheduled For February 24, 2026